35.25
Atricure Inc stock is traded at $35.25, with a volume of 395.47K.
It is up +1.09% in the last 24 hours and down -4.70% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$34.87
Open:
$34.71
24h Volume:
395.47K
Relative Volume:
0.79
Market Cap:
$1.75B
Revenue:
$499.95M
Net Income/Loss:
$-36.36M
P/E Ratio:
-45.78
EPS:
-0.77
Net Cash Flow:
$24.22M
1W Performance:
-3.79%
1M Performance:
-4.70%
6M Performance:
+9.27%
1Y Performance:
+25.71%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ATRC
Atricure Inc
|
35.25 | 1.73B | 499.95M | -36.36M | 24.22M | -0.77 |
![]()
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Resumed | JP Morgan | Overweight |
Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-29-23 | Initiated | UBS | Buy |
Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
Dec-18-20 | Reiterated | Needham | Buy |
Nov-06-20 | Reiterated | Needham | Buy |
Apr-07-20 | Initiated | Oppenheimer | Outperform |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-24-20 | Reiterated | Needham | Buy |
Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
Apr-12-19 | Initiated | JP Morgan | Overweight |
Oct-04-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Stifel | Buy |
Jun-18-18 | Reiterated | Needham | Buy |
Apr-27-18 | Reiterated | Needham | Buy |
Jan-16-18 | Reiterated | Needham | Buy |
Nov-02-17 | Reiterated | Needham | Buy |
Jul-28-17 | Reiterated | Needham | Buy |
May-30-17 | Resumed | Piper Jaffray | Overweight |
Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
Oct-28-15 | Reiterated | Needham | Buy |
Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
Can AtriCure Inc. hit a new high this monthTrade Exit Report & AI Powered Market Trend Analysis - newser.com
What analysts say about AtriCure Inc stockFlag and Pennant Patterns & Wealth Building Starts With One Click - earlytimes.in
Is now a turning point for AtriCure Inc.Quarterly Profit Report & Long-Term Investment Growth Plans - newser.com
AtriCure, Inc. $ATRC Stake Reduced by Assenagon Asset Management S.A. - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
U.S. Cryoablation Devices Market Set to Witness Significant Growth by 2025-2032 - openPR.com
AtriCure to anchor Mason’s new bioscience corridor, add 25 jobs - soapboxmedia.com
What Are the Top 8 Left Atrial Appendage Closure Device Companies in 2025 and How Are They Shaping the Industry? - Global Growth Insights
AtriCure, Inc. $ATRC Shares Sold by Rhumbline Advisers - MarketBeat
Will a bounce in AtriCure Inc. offer an exitJuly 2025 Review & Weekly High Potential Stock Alerts - newser.com
Is AtriCure's cryoXT FDA Clearance Reshaping the Investment Case for ATRC? - simplywall.st
First Bank & Trust Makes New Investment in AtriCure, Inc. $ATRC - MarketBeat
Street Watch: Will AtriCure Inc outperform the market in YEARJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - خودرو بانک
AtriCure, Inc. (NASDAQ:ATRC) Receives $50.89 Consensus Price Target from Analysts - MarketBeat
AtriCure (NASDAQ:ATRC) Insider Sells $108,900.00 in Stock - MarketBeat
AtriCure, Inc. Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends - Markets Mojo
CEO Moves: Will AtriCure Inc outperform the market in YEAR2025 Market Sentiment & Stock Market Timing Techniques - خودرو بانک
Trend analysis for AtriCure Inc. this weekTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Millennium Management LLC Has $20.11 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $70.87 Million Stock Holdings in AtriCure, Inc. $ATRC - MarketBeat
What MACD and RSI say about AtriCure Inc.Earnings Trend Report & Weekly Breakout Watchlists - newser.com
Sell Signal: Is AtriCure Inc. stock trending bullishEarnings Growth Summary & Verified Entry Point Detection - خودرو بانک
AtriCure (NASDAQ:ATRC) Stock Price Down 5.9%What's Next? - MarketBeat
AtriCure, Inc. $ATRC Shares Acquired by Advisors Capital Management LLC - MarketBeat
Has AtriCure Inc. found a price floorWeekly Profit Analysis & Weekly High Momentum Picks - newser.com
Aug Technicals: Will AtriCure Inc. outperform the market in YEARMarket Activity Recap & Safe Investment Capital Preservation Plans - خودرو بانک
AtriCure (ATRC) Unveils cryoXT Device for Advanced Post-Amputation Pain Management - Sahm
Osterweis Capital Management Inc. Acquires New Position in AtriCure, Inc. $ATRC - MarketBeat
Fund Flows: Will AtriCure Inc. outperform the market in YEAR - خودرو بانک
Market Leaders: What is AtriCure Incs revenue forecast2025 Valuation Update & Weekly Market Pulse Updates - خودرو بانک
Insider Sell: Justin Noznesky Sells 3,000 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure (ATRC) chief marketing officer sells $108,899 in stock By Investing.com - Investing.com South Africa
AtriCure (ATRC) chief marketing officer sells $108,899 in stock - Investing.com India
Profit Recap: Is AtriCure Inc undervalued by DCF analysis2025 Trading Recap & Weekly Stock Performance Updates - خودرو بانک
Shorts Report: Is AtriCure Inc undervalued by DCF analysisJuly 2025 Market Mood & Weekly Top Stock Performers List - خودرو بانک
Trade Report: What is AtriCure Incs book value per shareJuly 2025 Trends & Free Community Supported Trade Ideas - خودرو بانک
CEO Change: Is now the right time to enter AtriCure IncJuly 2025 Drop Watch & Safe Capital Growth Trade Ideas - خودرو بانک
Short interest data insights for AtriCure Inc.2025 Pullback Review & Scalable Portfolio Growth Methods - newser.com
How to read the order book for AtriCure Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
AtriCure, Inc. $ATRC Position Boosted by Acadian Asset Management LLC - MarketBeat
AtriCure, Inc. $ATRC Stock Position Lessened by Amundi - MarketBeat
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):